MetLife, Inc.
MET · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $16,881 | $17,176 | $18,263 | $18,440 |
| % Growth | -1.7% | -6% | -1% | – |
| Cost of Goods Sold | $13,944 | $12,636 | $13,542 | $13,576 |
| Gross Profit | $2,937 | $4,540 | $4,721 | $4,864 |
| % Margin | 17.4% | 26.4% | 25.9% | 26.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,529 | $1,545 | $1,563 | $1,509 |
| SG&A Expenses | $1,529 | $1,545 | $1,563 | $1,509 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $198 | $2,015 | $1,804 | $1,974 |
| Operating Expenses | $1,727 | $3,560 | $3,367 | $3,483 |
| Operating Income | $1,210 | $980 | $1,354 | $1,381 |
| % Margin | 7.2% | 5.7% | 7.4% | 7.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1,210 | $980 | $1,354 | $1,381 |
| Tax Expense | $308 | $245 | $404 | $106 |
| Net Income | $896 | $729 | $945 | $1,271 |
| % Margin | 5.3% | 4.2% | 5.2% | 6.9% |
| EPS | 1.23 | 1.04 | 1.29 | 1.79 |
| % Growth | 18.3% | -19.4% | -27.9% | – |
| EPS Diluted | 1.22 | 1.03 | 1.28 | 1.78 |
| Weighted Avg Shares Out | 665 | 671 | 682 | 696 |
| Weighted Avg Shares Out Dil | 669 | 675 | 687 | 698 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $271 | $269 | $258 | $259 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1,481 | $1,249 | $1,612 | $1,640 |
| % Margin | 8.8% | 7.3% | 8.8% | 8.9% |